InsiderTrades

Form 4 for TWST Twist Bioscience Corp

Accepted 2021-10-15 00:00:00 ET · period of report 2021-10-13 · accession 0001214659-21-010532 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-10-15 2021-10-13 TWST Leproust Emily M. Pres, CEO, Dir S - Sale+OE $110.16 -1,740 172.5K -1.0% -$191.7K
D 2021-10-15 2021-10-13 TWST Leproust Emily M. Pres, CEO, Dir M - OptEx $5.95 +1,740 174.2K +1% +$10.4K
D 2021-10-15 2021-10-13 TWST Leproust Emily M. Pres, CEO, Dir M - OptEx $0.00 -1,740 60.3K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-10-13 S D 1,740 $110.16 172,482 D — — (F2) Represents the weighted average sales price per share. The shares sold at prices ranging from $110 to $110.63 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
2 Common Common Stock 2021-10-13 M A 1,740 $5.95 174,222 D — —
3 Derivative Employee Stock Option (right to buy) 2021-10-13 M D 1,740 $0.00 60,253 D $5.95 · — to 2025-09-28 1,740 Common Stock (F6) The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.